Treatment with Aspirin and Dipyridamole is More Effective than Aspirin in Reducing Low Shear Blood Viscosity
- 1 October 2008
- journal article
- research article
- Published by Wiley in Microcirculation
- Vol. 15 (7) , 615-620
Abstract
Objective: Investigate effects of aspirin/dipyridamole and aspirin on blood viscosity (BV) in subjects with hyperhomocystememia (>14 μmol/L) and stable cardiovascular disease (CVD) or ≥ 20% risk for CVD were the aims of this study. Method: Forty‐seven subjects were treated with 14 days of either aspirin/dipyridamole (25 mg/200 mg twice‐daily) or aspirin (81 mg daily). BV was measured from fasting specimens at 37°C from whole blood at shear rates ranging from 1,000 to 1s−1 by using a scanning capillary viscometer (Rheolog™ Rheologics Inc., Exton, Pennsylvania, USA). Results: Aspirin/dipyridamole was more effective than aspirin therapy in reducing BV at shear rates of 1 s−1 (−3.03 [−3.88, −2.17] mPas vs. −0.07 [−1.06, 0.92] mPas; P−1 (−1.86 [−2.72, −1.01] mPas vs. −0.21 [−1.20, 0.79] mPas; P=0.0136); however, there were no significant differences in blood viscosity at shear rates of 5 s−1 to 1000 s−1. Changes in hematocrit, a major determinant of whole BV, were greater in the aspirin/dipyridamole group than the aspirin group (P=0.043). After hematocrit adjustment, differences in BV between aspirin/dipyridamole and aspirin remained significant at 1s−1 (−2.78 [−3.68, −1.88] mPas vs. −0.04 [−1.05, 0.98] mPas; P−1 (−1.62 [−2.52, −0.72] mPas vs. −0.17 [−1.19, 0.85] mPas; P=0.0315). Conclusion: These findings may have important clinical benefits in the CVD prevention and treatment due to the contribution of BV in tissue perfusion and thrombus formation.Keywords
This publication has 22 references indexed in Scilit:
- Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trialThe Lancet, 2006
- The Effect of Dipyridamole on Vascular Cell-Derived Reactive Oxygen SpeciesThe Journal of Pharmacology and Experimental Therapeutics, 2005
- AspirinJournal of Thrombosis and Haemostasis, 2004
- Failure of Pentoxifylline or Cilostazol to Improve Blood and Plasma Viscosity, Fibrinogen, and Erythrocyte Deformability in ClaudicationAngiology, 2002
- Blood viscosity and risk of cardiovascular events: the Edinburgh Artery StudyBritish Journal of Haematology, 1997
- Mechanisms of electromechanical coupling in membranes demonstrated by transmembrane potential-dependent shape transformations of human erythrocytesBioelectrochemistry and Bioenergetics, 1993
- Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke.Stroke, 1991
- Double-Blind, Crossover Study of the Clinical Efficacy and the Hemorheological Effects of Pentoxifylline in Patients With Occlusive Arterial Disease of the Lower LimbsAngiology, 1984
- Aspirin survival in human blood modulated by the concentration of erythrocytesArthritis & Rheumatism, 1982
- Rheological changes in the blood of patients with chronic arterial occlusive disease after the administration of vasoactive drugsCurrent Medical Research and Opinion, 1977